Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acral Nevus”

36 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 36 results

Early research (Phase 1)Looking for participantsNCT04485013
What this trial is testing

TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers

Who this might be right for
Cancer
Tizona Therapeutics, Inc 240
Testing effectiveness (Phase 2)Study completedNCT00470470
What this trial is testing

Imatinib Mesylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery

Who this might be right for
Acral Lentiginous Malignant MelanomaRecurrent MelanomaStage IIIA Melanoma+3 more
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Looking for participantsNCT05086692
What this trial is testing

A Beta-only IL-2 ImmunoTherapY Study

Who this might be right for
Advanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more
Medicenna Therapeutics, Inc. 115
Early research (Phase 1)Looking for participantsNCT04119024
What this trial is testing

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

Who this might be right for
Metastatic Malignant Solid NeoplasmMetastatic MelanomaPathologic Stage IIIC Cutaneous Melanoma AJCC v8+14 more
Anusha Kalbasi 18
Early research (Phase 1)Active Not RecruitingNCT03025256
What this trial is testing

Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal Disease

Who this might be right for
Acral Lentiginous MelanomaCentral Nervous System MelanomaClinical Stage IV Cutaneous Melanoma AJCC v8+7 more
M.D. Anderson Cancer Center 71
Testing effectiveness (Phase 2)Ended earlyNCT01120275
What this trial is testing

Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Stage IV Melanoma

Who this might be right for
Acral Lentiginous Malignant MelanomaLentigo Maligna Malignant MelanomaNodular Malignant Melanoma+4 more
National Cancer Institute (NCI) 36
Testing effectiveness (Phase 2)Study completedNCT00243061
What this trial is testing

AZD2171 in Treating Patients With Recurrent or Stage IV Melanoma

Who this might be right for
Acral Lentiginous Malignant MelanomaCiliary Body and Choroid Melanoma, Medium/Large SizeCiliary Body and Choroid Melanoma, Small Size+8 more
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Looking for participantsNCT05512481
What this trial is testing

Camrelizumab Plus Apatinib and Temozolomide as Neoadjuvant in High Risk Acral Melanoma

Who this might be right for
MelanomaAcral MelanomaTemozolomide+4 more
Peking University Cancer Hospital & Institute 60
Testing effectiveness (Phase 2)UnknownNCT03955354
What this trial is testing

PD-1 Antibody SHR-1210 Combined With Apatinib of First-line Treatment of Advanced Acral Melanoma

Who this might be right for
Melanoma
Peking University Cancer Hospital & Institute 30
Testing effectiveness (Phase 2)Study completedNCT00577382
What this trial is testing

SU011248 in Patients With Metastatic Mucosal or Acral/Lentiginous Melanoma

Who this might be right for
Mucosal Lentiginous MelanomaAcral Lentiginous Malignant Melanoma
Dana-Farber Cancer Institute 52
Early research (Phase 1)Ended earlyNCT04653038
What this trial is testing

Evaluate the Safety and Efficacy of MGD013 in Patients With Melanoma

Who this might be right for
Unresectable, Recurrent or Metastatic MelanomaUntreated Mucosal or Acral Lentiginous Melanoma
Zai Lab (Shanghai) Co., Ltd. 92
Testing effectiveness (Phase 2)Study completedNCT02071940
What this trial is testing

PLX3397 KIT in Acral aNd mucOsal Melanoma

Who this might be right for
Malignant Melanoma
The Christie NHS Foundation Trust 7
Early research (Phase 1)Study completedNCT00005057
What this trial is testing

Gene Therapy and Ganciclovir in Treating Patients With Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
National Human Genome Research Institute (NHGRI)
Testing effectiveness (Phase 2)Looking for participantsNCT04511013
What this trial is testing

Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

Who this might be right for
Acral Lentiginous MelanomaClinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Cutaneous Melanoma+4 more
SWOG Cancer Research Network 112
Testing effectiveness (Phase 2)WithdrawnNCT02535078
What this trial is testing

Phase 1b/2 Study of the Combination of IMCgp100 With Durvalumab and/or Tremelimumab in Advanced Cutaneous Melanoma

Who this might be right for
Malignant Melanoma
Immunocore Ltd
Testing effectiveness (Phase 2)Ended earlyNCT02978443
What this trial is testing

A Biomarker Study in Advanced Mucosal or Acral Lentiginous Melanoma Receiving Nivolumab in Combination With Ipilimumab

Who this might be right for
Acral Lentiginous MelanomaMucosal Melanoma
Georgetown University 14
Not applicableNot Yet RecruitingNCT06661577
What this trial is testing

An Observational Study Using The LumAssure Device In Participants Undergoing Assessment Of Skin Conditions.

Who this might be right for
Skin Cancers - Basal Cell CarcinomaSkin Cancers - Squamous Cell CarcinomaMelanoma of Skin+4 more
University of Auckland, New Zealand 3,000
Not applicableUnknownNCT00445783
What this trial is testing

Study of Families With Melanoma

Who this might be right for
Melanoma (Skin)
Leeds Cancer Centre at St. James's University Hospital 3,700
Testing effectiveness (Phase 2)Looking for participantsNCT06965231
What this trial is testing

Perioperative Toripalimab and Endostatin for Stage II Melanoma: A Phase II Trial

Who this might be right for
Melanoma of SkinAcral MelanomaStage II Melanoma
Fudan University 58
Testing effectiveness (Phase 2)Active Not RecruitingNCT00937937
What this trial is testing

Dinaciclib in Treating Patients With Stage IV Melanoma

Who this might be right for
Acral Lentiginous MelanomaCutaneous Nodular MelanomaLentigo Maligna Melanoma+4 more
National Cancer Institute (NCI) 72
Load More Results